Delayed Innovation

Getty images

Botox

A New Wrinkle

Botox, or botulinum toxin A, is just one high-profile example of a drug that doctors discovered had side effects offering unintended cosmetic benefits, which was later remarketed (after FDA approval) by pharmaceutical companies to reap increased profits. Allergan reported in 2006 that annual sales of Botox—initially used to treat a neurological movement disorder and approved in 2003 to smooth brow wrinkles—jumped 18.2%, to $982.2 million.

Read the story
Reader comments

More Slide Shows